Vertex Pharmaceuticals (VRTX)

Net Income Growth

6.48%

Quarterly · Period ending:

VRTX logo

VRTX Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported6.48%
VRTX Quarterly Net Income YoY % (-20.00% → 6.48%)
High-resolution chart · PNG

VRTX net income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Net Income Growth — Quarterly
Period endingNet Income Growth
6.4769%
59.5853%
30.46%
3.5871%
128.7428%
-41.2241%
-5.7597%
0.9756%
-492.4429%
57.1306%
18.305%
11.2628%
12.9796%
-8.1748%
6.3368%
9.2228%
1,111.0752%
16.6828%
27.4599%
27.6423%
-92.0069%
8.3591%
3.5931%
1,060.3915%
213.0836%
124.3795%
-62.3848%
-55.3244%
28.9675%
27.7595%
1,439.9934%
225.0544%
1,052.2561%
-15.133%
205.6124%
-146.0553%
127.89%
695.1238%
143.6288%
56.0258%
65.8323%
79.0384%
57.2548%
44.0497%
-18.4877%
14.5623%
-498.9071%
-37.007%
-178.8105%
24.5309%
158.1565%
-115.7083%
11.9604%
-436.2987%
-148.0038%
-126.0246%
62.6981%
152.0114%
187.9357%
205.816%
12.9681%
-6.5498%
-13.7087%
-39.7098%
-16.7598%
-1.5977%
-11.4605%
-15.0111%
-87.5768%
-69.1786%
-65.9829%
-21.499%
22.4562%
-19.1086%
-213.6008%
-106.6194%
-51.6483%
-61.1756%
28.2893%
34.9041%
-89.4652%
-12.0013%
10.8443%
-105.2513%
7.4115%
-10.589%
-4.2409%
55.1371%
3.3365%
-296.1962%
-27.8839%
-158.3433%
-117.8838%
193.4019%
-884.1411%
28.7922%
-73.6103%
-148.7824%
71.0325%
-88.9854%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.